Acellular Fetal Bovine Dermal Matrix for Treatment of Chronic Ulcerations of the Midfoot Associated With Charcot Neuroarthropathy

Foot and Ankle Specialist

Volumn 5, Issue 4, 2012, Pages 230-234

  Kavros, Steven J ^a  

^a MAYO CLINIC   (United States)

Author keywords

acellular collagen matrix; acellular fetal bovine dermal matrix; Charcot neuroarthropathy; ulcers

Indexed keywords

ACELLULAR DERMAL MATRIX; AGED; ANIMAL; ARTICLE; CATTLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; FOOT ULCER; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEUROPATHIC JOINT DISEASE; RETROSPECTIVE STUDY; SKIN TRANSPLANTATION; TREATMENT OUTCOME; WOUND HEALING;

ACELLULAR DERMIS; AGED; ANIMALS; ARTHROPATHY, NEUROGENIC; CATTLE; FEMALE; FOLLOW-UP STUDIES; FOOT ULCER; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN TRANSPLANTATION; TREATMENT OUTCOME; WOUND HEALING;

EID: 84864485227     PISSN: 19386400     EISSN: 19387636     Source Type: Journal    
DOI: 10.1177/1938640012449037     Document Type: Article

References (17)

1. van der Ven A,Chapman CB,Bowker JH.Charcot neuroarthropathy of the foot and ankle.J Am Acad Orthop Surg. 2009;17:562-571.
2. Sanders LJ.The Charcot foot: historical perspective 1827-2003.Diabetes Metab Res Rev. 2004;20:S4-S8.
3. Coughlin MJ,Mann RASurgery of the Foot and Ankle. 7th ed.St Louis, MO: Mosby; 1999.St Louis, MO: Mosby; 1999:.
4. Myerson MSFoot and Ankle Disorders. Philadelphia, PA: W. B. Saunders; 2000:.
5. Cornwell KG,Landsman A,James KS.Extracellular matrix biomaterials for soft tissue repair.Clin Podiatr Med Surg. 2009;26:507-523.
6. Martin BR,Sangalang M,Wu S,Armstrong DG.Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience.Int Wound J. 2005;2:161-165.
7. Reyzelman A,Crews RT,Moore JC, et al.Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study.Int Wound J. 2009;6:196-208.
8. Ruszczak Z.Effect of collagen matrices on dermal wound healing.Adv Drug Deliv Rev. 2003;55:1595-1611.
9. Landsman A,Taft D,Riemer K.The role of collagen bioscaffolds, foamed collagen, and living skin equivalents in wound healing.Clin Podiatr Med Surg. 2009;26:525-533.
10. Kavros SJ,Van Straaten MG,Coleman Wood KA,Kaufman KR.Forefoot plantar pressure reduction of off-the-shelf rocker bottom provisional footwear.Clin Biomech. 2011;26:778-782.
11. Karau MJ,Piper KE,Steckelberg JM,Kavros SJ,Patel R.In vitro activity of the Qoustic Wound Therapy System against planktonic and biofilm bacteria.Adv Skin Wound Care. 2010;23:316-320.
12. Altman DGPractical Statistics for Medical Research. Boca Raton, FL: Chapman & Hall/CRC Press; 1999:.
13. Ince P,Game FL,Jeffcoate WJ.Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area.Diabetes Care. 2007;30:660-663.
14. Margolis DJ,Kantor J,Berlin JA.Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.Diabetes Care. 1999;22:692-695.
15. Marston WA,Hanft J,Norwood P,Pollak R.The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.Diabetes Care. 2003;26:1701-1705.
16. Veves A,Falanga V,Armstrong DG,Sabolinski ML.Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.Diabetes Care. 2001;24:290-295.
17. Katz IA,Harlan A,Miranda-Palma B, et al.A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers.Diabetes Care. 2005;28:555-559.